+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 3
Age: 4Years - 21Years
All Genders
ID05382338

Phase 3 Trial of Sodium Thiosulfate to Reduce Hearing Loss and Reduced Radiation Therapy for Children With Medulloblastoma

Led by Children's Oncology Group · Updated on 2026-08-25

225

Participants Needed

111

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating treatments for children and young adults with low-risk and average-risk medulloblastoma, a type of brain cancer. This phase III trial aims to test two main ideas whether adding sodium thiosulfate STS to standard chemotherapy and radiation can reduce hearing loss caused by cisplatin in average-risk patients, and whether a less intense radiation therapy can be as effective for low-risk patients while reducing side effects. The study also compares outcomes to previous treatments to ensure survival and recurrence rates are not negatively affected. Participants receive radiation therapy daily for 6 weeks and weekly vincristine during treatment weeks. Maintenance therapy begins about 4 weeks later and includes cycles of oral lomustine, intravenous cisplatin, intravenous sodium thiosulfate, cyclophosphamide, and vincristine given on specific days and cycles over several months. Patients undergo MRI scans and cerebrospinal fluid collections throughout the study, with optional blood samples. After treatment, follow-up visits occur regularly for up to 10 years. Throughout the study, participants have hearing tests, brain scans, and lab tests to monitor effects and side effects. Researchers assess hearing loss, event-free and overall survival, kidney function, neurocognitive outcomes, quality of life, and social factors. Hearing loss is evaluated shortly after treatment and over time. This long-term monitoring helps understand the safety and impact of the treatments, with total involvement lasting up to 10 years after starting therapy.

CONDITIONS

Brief Title

A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here